Cerebrolysin
Also known as: FPF 1070 · EVER Neuro Pharma peptides · Porcine brain peptide mixture
Cerebrolysin is a complex mixture whose biological activity resembles that of neurotrophic factors. Its low-molecular-weight peptide fractions cross the blood-brain barrier and mimic the effects of BDNF, NGF, CNTF, and IGF-1 in neural tissue. Mechanisms include: (1) Neurotrophic — promotes...
What It Is
Cerebrolysin is a complex mixture whose biological activity resembles that of neurotrophic factors. Its low-molecular-weight peptide fractions cross the blood-brain barrier and mimic the effects of BDNF, NGF, CNTF, and IGF-1 in neural tissue. Mechanisms include: (1) Neurotrophic — promotes neuronal survival, differentiation, and axonal growth; reduces excitotoxic damage from glutamate. (2) Neuroprotective — reduces amyloid precursor protein (APP) processing and amyloid-beta formation; reduces tau hyperphosphorylation; inhibits calpain-mediated degradation after ischemia. (3) Neuroplastic — enhances LTP, promotes synaptogenesis, and improves neurogenesis in the hippocampus. (4) Metabolic — improves cerebral oxidative energy metabolism and glucose utilization. Clinical evidence supports its use in Alzheimer's disease, vascular dementia, and stroke recovery.
Supplies Needed
IM injection
IV infusion dilution
IV administration
Sterilization
Storage
N/A — supplied as liquid solution
Unopened: store at 15–25°C (room temperature). Opened: use immediately.
This information is provided for educational and research purposes only. Not approved for human consumption by the FDA or any regulatory body. Always consult a qualified medical professional.
Dosing Protocols
Timing: Morning. Standard clinical preparation is 215 mg/mL in 5 mL or 10 mL vials. Start with 1 mL/day IM for tolerability.
↓ Apply these values to the reconstitution calculatorTiming: Morning, slow IV infusion or deep IM. The European clinical standard is IV infusion of 5u201310 mL over 20 days. IM injection is used by biohackers as a practical alternative.
↓ Apply these values to the reconstitution calculatorTiming: Morning over 30-minute IV infusion. Advanced protocols use IV infusion for maximum CNS bioavailability. Medical supervision recommended for IV use.
↓ Apply these values to the reconstitution calculatorWeekly Timeline
| Week | Expected Effects |
|---|---|
| Week 1 | Improved mental clarity; reduced cognitive fatigue; some users report improved mood within first week |
| Week 2 | Enhanced memory consolidation; improved attention span; neuroplasticity effects developing |
| Week 3 | Peak cognitive enhancement during 20-day course; improved processing speed; mood stabilization |
| Week 4 | Completion of standard course; cognitive improvements often persist for weeks to months after course ends |
Reconstitution Calculator
1 unit on U-100 syringe = 0.01 mL · Always label your vial after reconstitution
Injection Technique & Reconstitution
- Cerebrolysin is supplied as a ready-to-use sterile solution u2014 no reconstitution required
- For IM injection: draw required volume directly from vial with sterile syringe
- For IV use: dilute in 100 mL normal saline (0.9% NaCl); infuse over 20u201330 minutes
- Do not mix with other drugs in the same infusion
- Store unopened vials at 15u201325u00b0C; do not refrigerate or freeze
- Use immediately after opening; discard any unused portion
Use our free peptide reconstitution calculator to get the exact syringe units for your vial size and dose.
Mechanism of Action
Cerebrolysin is a complex mixture whose biological activity resembles that of neurotrophic factors. Its low-molecular-weight peptide fractions cross the blood-brain barrier and mimic the effects of BDNF, NGF, CNTF, and IGF-1 in neural tissue. Mechanisms include: (1) Neurotrophic — promotes neuronal survival, differentiation, and axonal growth; reduces excitotoxic damage from glutamate. (2) Neuroprotective — reduces amyloid precursor protein (APP) processing and amyloid-beta formation; reduces tau hyperphosphorylation; inhibits calpain-mediated degradation after ischemia. (3) Neuroplastic — enhances LTP, promotes synaptogenesis, and improves neurogenesis in the hippocampus. (4) Metabolic — improves cerebral oxidative energy metabolism and glucose utilization. Clinical evidence supports its use in Alzheimer's disease, vascular dementia, and stroke recovery.
Key Research Papers
Meta-analysis of RCTs showing Cerebrolysin significantly improved neurological outcomes and functional recovery in traumatic brain injury patients compared to placebo.
View on PubMed →RCT demonstrating Cerebrolysin treatment produced significant improvements in cognitive function and global clinical status in mild-to-moderate Alzheimer's disease patients.
View on PubMed →Stacks Well With
Semax raises BDNF and NGF in the CNS; Cerebrolysin delivers BDNF-like peptide fractions directly u2014 synergistic neurotrophin amplification for cognitive enhancement and neuroprotection
Dihexa is an extremely potent synaptogen via HGF/c-Met; Cerebrolysin provides neurotrophin-like support u2014 together powerful for cognitive restoration and synaptogenesis
Selank provides anxiolytic and mild nootropic effects; Cerebrolysin provides structural neuroprotection u2014 comprehensive neurological health stack
Frequently Asked Questions
Cerebrolysin is not FDA approved in the United States. It is approved and widely used in Europe, Asia, and Russia for stroke, TBI, Alzheimer's disease, and vascular dementia, particularly in post-Soviet countries where it is a first-line neurological treatment.
Yes u2014 Cerebrolysin is produced by controlled enzymatic hydrolysis of purified porcine brain proteins. The resulting peptide fractions are extensively purified and standardized. Patients with pig-related allergies or religious restrictions should be aware of this.
Standard European clinical practice uses 20-day intensive courses repeated every 1u20133 months, depending on the indication. Cognitive enhancement biohackers typically do 2u20134 courses per year.
Yes u2014 IM injection is practical for outpatient or self-administration use. Typical dose is 1u20135 mL IM. IV infusion is preferred clinically for higher doses (10 mL+) due to faster and more complete CNS delivery.
Legal Status by Region
This information is provided for educational and research purposes only. Not approved for human consumption by the FDA or any regulatory body. Always consult a qualified medical professional.